Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial
Abstract. Background. Randomized trials have shown that early adoption of everolimus-based immunosuppressive regimens without a calcineurin inhibitor (CNI) imp
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
10 June 2017
|
| In: |
Nephrology, dialysis, transplantation
Year: 2017, Volume: 32, Fascicolo: 6, Pages: 1060-1070 |
| ISSN: | 1460-2385 |
| DOI: | 10.1093/ndt/gfx075 |
| Accesso online: | Verlag, Volltext: http://dx.doi.org/10.1093/ndt/gfx075 Verlag, Volltext: https://academic.oup.com/ndt/article/32/6/1060/3866771 
|
| Note sull'autore: | Klemens Budde, Martin Zeier, Oliver Witzke, Wolfgang Arns, Frank Lehner, Markus Guba, Johannes Jacobi, Volker Kliem, Petra Reinke, Ingeborg A. Hauser, Bruno Vogt, Rolf Stahl, Thomas Rath, Michael Duerr, Eva-Maria Paulus, Christoph May, Martina Porstner, Claudia Sommerer on behalf of the HERAKLES Study Group |
| Riassunto: | Abstract. Background. Randomized trials have shown that early adoption of everolimus-based immunosuppressive regimens without a calcineurin inhibitor (CNI) imp |
|---|---|
| Descrizione del documento: | Gesehen am 23.08.2018 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1460-2385 |
| DOI: | 10.1093/ndt/gfx075 |